WHAT IS GENOMICS
Genome is a word used to describe the genetic make-up of an individual. This includes our genes that are passed on from parent to offspring. Our genes contribute to many of our physical characteristics (i.e. eye colour and height). They can also impact our lifetime risk of developing certain medical conditions.
Genomics is a branch of science that studies the genome. Genomics looks at how our genes interact with each other, how they function and how they are structured. This study also compares how genomes are similar, and different, across animal species. Using a variety of scientific techniques all of this data is organized into databases which allows our scientists to further understand the genetic basis of disease.
Improving health through translational genomics.
To deliver medical genomic research that translates into life-changing tests and treatments for people affected by acquired and inherited diseases.
Through ongoing resource and facility partnerships, CGEM has the infrastructure, knowhow, and network of dedicated members to ensure its research discoveries are translated into new patient-oriented treatments.
OUR EXECUTIVE TEAM
The CGEM’s executive is made up of an inter-disciplinary team of eight, whose work and expertise span across multiple organizations in a variety of fields.
CGEM DIRECTOR IWK & DALHOUSIE, Ophthalmology & Visual Sciences, and Pathology & Pediatrics
DALHOUSIE UNIVERSITY: Associate Director Life and Health Sciences
DALHOUSIE: Carnegie & Rockefeller Professor, Dept. Pharmacology Head
IWK & DALHOUSIE, Pediatric Medicine
DALHOUSIE, Ophthalmology & Visual Sciences
With a strong research collaboration of over 50 members, CGEM has a large asset map of expertise, publications, technology, and resources across a significant network. These capabilities enable CGEM scientists and clinicians to make ground-breaking research discoveries in the areas of orphan disease gene and drug discovery, cancer diagnostics and the medical microbiome.
Distribution of CGEM Members
Through ongoing partnerships with AGADA Biosciences Inc., the Centre for Drug Research and Development, Dalhousie University, the IWK Health Centre and the Nova Scotia Health Authority, CGEM has the infrastructure, knowhow, and dedication to ensure its discoveries are translated into new patient-oriented treatments that will make a significant impact in Canada and around the world.